| Home | Search | Study Topics | Glossary |
|
|
|
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| Sponsored by: |
National Institute of Neurological Disorders and Stroke (NINDS) |
| Information provided by: | National Institutes of Health Clinical Center (CC) |
| ClinicalTrials.gov Identifier: | NCT00001549 |
Purpose
The purpose of this study is to improve understanding of neurological conditions. Patients participating in this study will continue receiving medical care, routine laboratory tests, and diagnostics tests (X-rays, CT-scans, and nuclear imaging), from their primary care physician. Doctors at the NIH plan to follow these patients and offer advice and assistance to their primary care physicians.
| Condition |
|
Alzheimer's Disease Dementia Movement Disorder Multiple System Atrophy Parkinson's Disease |
| Genetics Home Reference related topics: | Alzheimer disease familial paroxysmal nonkinesigenic dyskinesia Parkinson disease |
| MedlinePlus related topics: | Alzheimer's Disease Dementia Movement Disorders Parkinson's Disease |
| Study Type: | Observational |
| Official Title: | Diagnosis and Natural History Protocol for Patients With Neurological Conditions |
| Estimated Enrollment: | 600 |
| Study Start Date: | October 1995 |
| Estimated Study Completion Date: | January 2006 |
The objective of this protocol is to provide diagnosis and follow Experimental Therapeutics Branch (ETB) patients not currently entered on another research protocol. No investigational treatments will be administered on this protocol, and the NIH physicians will be playing largely a consultative role to the patient's primary physician.
Eligibility
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
INCLUSION CRITERIA:
Patients may be included on this protocol if they have an identifiable neurological disorder or represent a diagnostic puzzle. These disorders would include patients with Parkinson's disease, Alzheimer's disease, multiple system atrophy, progressive supranuclear palsy, restless legs syndrome, other cognitive and movement disorders, and diagnostic puzzles.
Patients 18-90 years of age, inclusive, are eligible.
Contacts and Locations More Information
| Study ID Numbers: | 960009, 96-N-0009 |
| First Received: | November 3, 1999 |
| Last Updated: | March 3, 2008 |
| ClinicalTrials.gov Identifier: | NCT00001549 |
| Health Authority: | United States: Federal Government |
|
|
|
|
|
|
